E

Eikon Therapeutics

Biotechnology Research · United States · 500 employees

93 Decision makers
+7 New (6 months)
500 Employees
$6M Revenue
2019 Founded

Organizational Chart of Eikon Therapeutics

Roles identified within Eikon Therapeutics's leadership team, from public professional data, updated 25 Oct 2026.

Department

Hiring This department is actively hiring right now.

Eikon Therapeutics's Full Organizational Chart

Loading…

Get their contacts on Zeliq →

Job title Department People Action

Decision makers at Eikon Therapeutics by function

General management

Finance

Tech & product

Other functions

See all Eikon Therapeutics contacts on Zeliq

Decision makers at Eikon Therapeutics

93 identified 5 C-Level 12 VP 76 Directors +7 new (6 months)
See them on Zeliq →

Departments actively hiring 3 departments

Medical
Operations
Research

These departments at Eikon Therapeutics are actively recruiting: a strong signal to time your outreach.

Funding and news at Eikon Therapeutics

Funding

Last round Series D · $351M
Total funding $1.1B (5 rounds)
Seed Round N/A Jan 2019
Series A $148M May 2021
Series B $518M Jan 2022
Series C $106M Jun 2023
Series D $351M Mar 2025

Latest news at Eikon Therapeutics

  1. Appointment

    New Senior Director of Biostatistics appointed — Research

  2. Appointment

    New Director Clinical Study Management appointed — Medical

  3. Appointment

    New Director appointed — General management

  4. Appointment

    New Associate Director, Drug Safety appointed — Medical

  5. Appointment

    New Senior Director of Security appointed — Operations

Get these new hires' email and phone →

Team Structure headcount by department

Hiring Research
115
Technical
58
Hiring Medical
38
Hiring Operations
30
Other
23
General Management
21
Project Management
21
Legal
10

How to prospect Eikon Therapeutics's departments

Research

With 115 people, this is the organisation's biggest team, and it is hiring. Long cycles and rigorous methods: respect their pace and bring evidence, not hype.

Technical

With 58 people, this is the organisation's second pillar. Skip the marketing speak: these decision makers expect precise use cases, documentation and a quick proof of value.

Medical

This 38-person department is actively recruiting. Regulatory constraints and protocols shape everything here: show you understand their compliance context before pitching.

Operations

Hiring is underway in this team of 30 people. Process efficiency and cost control are the angles that resonate with these decision makers.

Other

A team of 23 people. Hard to read from the outside: use a first exchange to map who does what before pushing an offer.

General Management

This department counts 21 people. Executive attention is scarce: one sharp sentence on business impact beats three paragraphs of features.

Try the Zeliq email finder demo →

FAQ Eikon Therapeutics

Who runs Eikon Therapeutics?

The highest-ranking leadership role identified at Eikon Therapeutics is “CFO”, based on public data updated 25 Oct 2026.

How many decision makers does Eikon Therapeutics have?

93 decision makers identified, including 5 at executive level.

How do I contact a decision maker at Eikon Therapeutics?

Verified emails and phone numbers are available in Zeliq, with free credits at sign-up.

Which departments are hiring at Eikon Therapeutics?

Medical, Operations and Research, based on published job offers as of 25 Oct 2026.

Companies similar to Eikon Therapeutics

More companies to explore

Biotechnology Research · United States

All Biotechnology Research companies in United States →

About Eikon Therapeutics

Eikon Therapeutics is a company active in the Biotechnology Research space, based in United States. Established in 2019, it counts about 500 employees. Within the wider Professional Services sector, Eikon Therapeutics focuses on the Biotechnology Research segment. Eikon Therapeutics sells primarily to other businesses (B2B) rather than to end consumers. Eikon Therapeutics has raised funding across 5 rounds totalling $1.1B. The company generates approximately $6M in annual revenue. Use this page to review Eikon Therapeutics's industry, headcount, location and hiring signals, and to reach verified B2B contacts before your next outreach.

Activity & Market

The company evolves in the Biotechnology Research segment of the Professional Services sector. As a B2B company, Eikon Therapeutics primarily serves business clients and professional organisations. In terms of structure, it is registered as “Privately held”.